Key result
Measuring APC resistance without factor V-deficient plasma dilution detects thrombotic risks beyond factor V Leiden.
Why the study?
Does measurement of APC resistance without dilution in factor V-deficient plasma detect thrombotic risk factors other than Factor V Leiden?
Case-Control (n=65)
Blinded
Does measurement of APC resistance without dilution in factor V-deficient plasma detect thrombotic risk factors other than Factor V Leiden?
Measurement of APC resistance without dilution in factor V-deficient plasma can identify potentially important thrombotic risk factors beyond Factor V Leiden.
Answers are grounded in this paper and cite their sources.
May detect additional thrombotic risks beyond FV Leiden; hypothesis-generating and should not yet change testing practice.
Activated protein C (APC) resistance is a common risk factor for venous thromboembolism (VTE) attributed to various mechanisms, including factor V Leiden (FVL) polymorphism. FVL is considered responsible for up to 95% of APC resistance; however, other factor V polymorphisms and elevated factor VIII levels also have been implicated. We assessed whether additional mechanisms contribute to APC resistance in a blinded case-control study of 65 subjects by measuring APC resistance using 3 methods: 2 activated partial thromboplastin time–based methods with and without dilution in factor V–deficient plasma and 1 Russell viper venom–based assay (RVV). Without factor V–deficient plasma, 24 subjects were APC resistant; with factor V–deficient plasma, the assay identified fewer APC-resistant subjects, as did RVV. All assays detected the 7 heterozygous FVL subjects. Thirteen subjects had factor VIII levels above 150% (1.50). After excluding subjects with FVL or elevated factor VIII levels, 4 subjects still had APC resistance. VTE risk trended higher for subjects with APC resistance in the absence of FVL. Measurement of APC resistance without dilution in factor V–deficient plasma is needed to assess for potentially important thrombotic risk factors other than FVL.
No takes yet. Share an insight, caveat, or question.
Graf et al. (2003) conducted a case-control in Venous thromboembolism (n=65). Activated protein C (APC) resistance assay without dilution in factor V-deficient plasma vs. Assays with dilution in factor V-deficient plasma or RVV was evaluated on Detection of APC resistance. Measurement of APC resistance without dilution in factor V-deficient plasma identified 24 APC-resistant subjects, detecting thrombotic risk factors other than factor V Leiden.
Synapse has enriched 10 related papers. Consider them for comparative context: